Exogenous insulin-like growth factor 1 attenuates cisplatin-induced muscle atrophy in mice.

Background: A reduction in the skeletal muscle mass worsens the prognosis of patients with various cancers. Our previous studies indicated that cisplatin administration to mice caused muscle atrophy. This is a concern for human patients receiving cisplatin.